Actionable news
0
All posts from Actionable news
Actionable news in ACOR: Acorda Therapeutics, Inc.,

Acorda Therapeutics Inc.

Average Recommendation: Overweight Average Target Price: 41.62
Number of Ratings: 7 Current Quarters Estimate: 0.24
FY Report Date: 12 / 2016 Current Year's Estimate: 0.76
Last Quarter's Earnings: 0.07 Median PE on CY...

More